AstraZeneca emphasizing transparency
Executive Summary
In efforts to increase transparency, AstraZeneca plans to make medical education grants, third party contributions and post-marketing study commitments public this fall, and political contribution postings are expected in the second quarter. "We understand that to make a difference to patient health it's important for us to be open," AstraZeneca told "The Pink Sheet." The information will be available through a link on the company site, and some that is already public, such as clinical trial data and compliance program information, will be made more visible